$140.4-220k
+ cash bonus and stock option
Medical equipment manufacturing
Be an early applicant
Medical equipment manufacturing
501-1000 employees
Be an early applicant
$140.4-220k
+ cash bonus and stock option
501-1000 employees
To save lives, improve the patient experience and reduce the overall costs of care.
HeartFlow was founded in 2007 and is a medical equipment manufacturer that uses CT-scanned 3D modelling to assess and analyze a patient's arteries. This noninvasive process can help assess the risks of heart disease and strategize the appropriate treatment.
HeartFlow has had a long history of awards and innovations. In 2021, it brought its technology to the NHS in England and in October 2022, introduced a plaque analysis service. As time has gone on, Heartflow has indicated that it is keeping up with technological advances and finding new ways to provide heart health services through them.
HeartFlow successfully launched its IPO in 2021 but faced a setback when its merger with Longview Acquisitions was called off in 2022 due to unfavourable market conditions. Despite this, the company has made a strong comeback and recently unveiled its next-generation plaque analysis AI, demonstrating its continued commitment to innovation and growth.
Steph
Company Specialist at Welcome to the Jungle
Apr 2023
$215m
SERIES F
Jun 2019
$65m
LATE VC
Old Mountain View, Mountain View, CA
John Farquhar
(CEO)Joined HeartFlow in 2021 as the President and Chief Operating Officer and became the CEO in 2022. Prior to this, they were the VP and General Manager at Medtronic. They also spent 5 years as a Professional Football Player in the NFL.
Share this job
View 8 more jobs at HeartFlow